Replies to post #29140 on Humanigen Inc (HGENQ)

[10nisman]

At some point, speculation will be unnecessary, and we will know how much product has been sold, and how much revenue will be raised. Until I get some informed guidance, I stand by what I projected the other day, a Market Cap of $250B, and a share price of $4,200. That's actually assuming that some of these other therapeutics capture a significant portion of the market.

BLAHAHAHA!! HGEN would be the 23rd most valued company in the S&P 500 if that was true. Bigger than Pfizer, Merck, Abbott, Abbvie, Bristol Myers, Amgen, Intel, Coke, Exxon Mobil, Cisco, etc.